Healthcare
HealthEquity, Inc.(HQY)
Live Price
Offline$86.33
+0.78% today
1Y Change
-16.97%
Window
Jun 25, 2025 โ Jun 17, 2026
- Market Cap
- $6.93B
- Revenue Growth
- +9.5%
- EPS Growth
- +125.2%
- Dividend Yield
- 0.0%
Coverage: 246 bars ยท Jun 25, 2025 โ Jun 17, 2026
Research Briefing
A compact read on the setup, peer context, quarterly changes, and recent earnings reaction.
Research Snapshot
HealthEquity, Inc. (HQY) is a Healthcare stock with a market cap of $6.93B and listed on NASDAQ. The stock last traded around $86.33 and down 17.0% across the available one-year price window (Jun 25, 2025 โ Jun 17, 2026). Baseline metrics include revenue growth of +9.5%, EPS growth of +125.2%, a dividend yield of 0.0%. What stands out right now is revenue +9.5%, EPS +125.2%, free cash flow +34.7% with operating margin 24.6% and ROIC 7.6%. Valuation already assumes a fairly strong business story at P/E 32.8 and price/sales 5.3. Stock Foundry combines HQY price history, valuation, growth, dividend context, earnings, analyst forecasts, news, related Healthcare peers on this page.
Sector Context
How this name stacks up against nearby peers on first-pass metrics.
Revenue Growth
Near sector median
+9.5% vs +7.6% peer median
Operating Margin
Above sector median
+24.6% vs +19.4% peer median
P/E
Below sector median
32.8 vs 36.3 peer median
What Changed This Quarter
Latest report context and the signals most likely to have changed the story.
Latest report is on the board
Q2 2026 was reported on May 31, 2026, but the surprise data is still limited.
The operating story is still moving forward
Revenue is running at +9.5% and EPS at +125.2%, with operating margin around 24.6%.
Earnings Reaction Memory
How the stock has tended to move after recent reports.
Across the last 3 reported quarters, the stock averaged -0.4% over the next 5 trading days and finished higher after 1 of those reports.
View quarter-by-quarter reaction table
| Quarter | EPS ฮ | 1D | 5D | 20D |
|---|---|---|---|---|
Q2 2026 May 31, 2026 | โ | -2.5% | -3.1% | โ |
Q2 2026 Apr 27, 2026 | +16.7% | -2.8% | -1.6% | +4.5% |
Q1 2026 Mar 17, 2026 | +5.6% | +0.2% | +3.4% | +5.4% |
Benchmark Edge
HQY vs SPY, QQQ, and Sector ETFs
Normalized return, excess return, max drawdown, and calendar-year wins against the benchmarks investors actually use.
HQY
โ
Normalized return
SPY
--
S&P 500
Excess Return
--
Relative to SPY
HQY Max Drawdown
-30.57%
Trailing 1Y
SPY Max Drawdown
โ
Trailing 1Y
Calendar-Year Returns
Uses the longest available daily history for HQY and SPY.
Company Overview
HealthEquity, Inc.
NASDAQ Global Select
HealthEquity, Inc. provides technology-enabled services platforms to consumers and employers in the United States. The company offers cloud-based platforms for individuals to make health saving and spending decisions, pay healthcare bills, compare treatment options and prices, receive personalized benefit and clinical information, earn wellness incentives, grow their savings, and make investment choices; and health savings accounts. It also provides mutual fund investment platform; and online-only automated investment advisory services through Advisor, a Web-based tool. In addition, the company offers flexible spending accounts; health reimbursement arrangements; and Consolidated Omnibus Budget Reconciliation Act continuation services, as well as administers pre-tax commuter benefit programs. It serves clients through a direct sales force; benefits brokers and advisors; and a network of health plans, benefits administrators, benefits brokers and consultants, and retirement plan record-keepers. The company was incorporated in 2002 and is headquartered in Draper, Utah.
- Leadership
- Scott R. Cutler
- IPO Date
- Jul 31, 2014
- Employees
- 3.1k
- Street Address
- 15 West Scenic Pointe Drive
- Mailing
- Draper, UT, 84020
- Region
- Draper, UT, US
- Reporting Currency
- USD
- Investor Line
- 801 727 1000
- Last Updated
- Apr 30, 2026
Key Fundamentals
Valuation, growth, profitability, and balance sheet signals.
Valuation
- P/E
- 32.8
- EV/EBITDA
- 23.6
- Price/Sales
- 5.3
- Price/Book
- 3.4
Growth
- Revenue
- +9.5%
- EPS
- +125.2%
- Free Cash Flow
- +34.7%
Profitability
- Gross Margin
- 69.5%
- Operating Margin
- 24.6%
- Net Margin
- 16.4%
- ROE
- 10.1%
- ROIC
- 7.6%
Balance Sheet
- Debt/Equity
- 0.48
- Current Ratio
- 3.27
Earnings Reports
Latest News
Official Releases
Company announcements and filings-style updates.
Next Step
Keep the research moving
After the overview, the strongest next step is usually chart context or a tighter compare set.